Technologies related to Therapeutic (biologic)

Title
Monoclonal Antibodies that Neutralize Norovirus
Ref: E-226-2011-0 | Updated: Jul 6, 2020
Gene Therapy for Niemann-Pick Disease Type C
Ref: E-185-2014-0 | Updated: Sep 28, 2020
Encapsulated Streptococcus Compositions and Methods for Pneumococcal Vaccine, Probiotic, and Diagnostic Assay Development
Ref: E-009-2018-0 | Updated: Feb 26, 2019
Human Retrovirus Obtained from Infected Chimpanzee Exposure
Ref: E-251-2013-0 | Updated: Sep 10, 2018
Licensing Availability: Methods of Diagnosing and Treating CHAPLE, A Newly Identified Orphan Disease
Ref: E-251-2016-0 | Updated: Sep 7, 2018
New Anti-Influenza Virus Neuraminidase 9 (N9) Monoclonal Antibody – for Prevention or Treatment of H7N9 Influenza (Flu) A with Less Likelihood of Drug Resistance
Ref: E-200-2016-0 | Updated: Jun 20, 2018
Novel Fourth Human Ebolavirus species, Bundibugyo ebolavirus – Compositions and Methods for Vaccine, Therapeutics and Highly Sensitive Diagnostic Assay Development
Ref: E-159-2013-0 | Updated: Jun 7, 2018
Heartland Virus Humanized Monoclonal Antibodies for Diagnostic and Therapeutic Development
Ref: E-293-2014-1 | Updated: Feb 14, 2018
Regenerative Therapy for Cartilage Damage
Ref: E-152-2017-0 | Updated: Jan 25, 2018
Neutralizing Antibodies to Influenza HA and Their Use and Identification
Ref: E-061-2016-0 | Updated: Jun 22, 2018
Chimeric Antibodies Against Hepatitis B e-Antigen
Ref: E-192-2017-0 | Updated: Jan 31, 2018
Efficient mRNA-Based Genetic Engineering of Human NK Cells with High-Affinity CD16 and CCR7
Ref: E-036-2015-0 | Updated: May 17, 2017
Capsid-Free AAV Vectors for Gene Delivery and Their Use for Gene Therapy
Ref: E-241-2010-0 | Updated: Oct 12, 2016
Long Acting Therapeutic Conjugates with Evans Blue
Ref: E-143-2015-0 | Updated: Jun 27, 2016
Tagged Form of Mut Enzyme and Its Use in Gene Therapy
Ref: E-090-2015-0 | Updated: Apr 18, 2016
Mice with a Floxed Allele of the alpha Subunit of the Heterotrimeric G Protein Go or Gi2
Ref: E-071-2014-0 | Updated: May 14, 2018
TRPC Knockout (KO) Mice and Mice with a Floxed Allele of TRPC Ion Channel Genes
Ref: E-071-2014-2 | Updated: May 14, 2018
Mouse Model for Study of Diabetic Nephropathy and Role of Soluble Epoxide Hydrolase
Ref: E-292-2015-0 | Updated: May 24, 2016
Novel Treatment for Anemia and Polycythemia: AVPR1B Molecules Modulating Erythropoiesis
Ref: E-619-2013-0 | Updated: Aug 6, 2015
Modified AAV5 Vectors for Enhanced Transduction and Reduced Antibody Neutralization
Ref: E-097-2015-0 | Updated: May 1, 2019
A Novel Adeno-Associated Virus for Gene Therapy
Ref: E-175-2015-0 | Updated: May 1, 2019
Device for Selective Partitioning of Frozen Cellular Products
Ref: E-173-2009-0 | Updated: Jun 29, 2015
A Novel Therapeutic Vector for Hemoglobin Disorders
Ref: E-165-2014-0 | Updated: Sep 21, 2015
CXCR4 Reduction Leads to Enhancement of Engraftment of Hematopoietic Stem Cells
Ref: E-173-2014-0 | Updated: Jul 1, 2015
T Cell-Based Adoptive Transfer Immunotherapy for Polyomavirus-Associated Pathologies
Ref: E-166-2014-0 | Updated: Sep 12, 2017
The Use of Chimeric Antigen Receptor to Control HIV Infection
Ref: E-212-2014-0 | Updated: Sep 9, 2015
A Novel Fusion Protein for Inhibiting HIV Budding
Ref: E-223-2014-0 | Updated: May 10, 2018
Monitoring the Effects of Sleep Deprivation Using Neuronal Avalanches
Ref: E-345-2013-0 | Updated: Aug 17, 2016
Polypeptides and Methods for Enhancing and Balancing Monovalent or Multivalent Flavivirus Vaccines
Ref: E-275-2013-0 | Updated: Jan 27, 2020
Treatment of Chronic Kidney Disease with Synthetic Amphipathic Peptides
Ref: E-743-2013-0 | Updated: Jun 2, 2014
Discrete Cross-Reactive Epitopes for Flavivirus Serological Diagnostics and Vaccines
Ref: E-333-2013-0 | Updated: May 15, 2014
MDCK-based Reporter System for Detection of Influenza Viruses, Antiviral Drug Screening, and Analysis of Neutralizing Antibodies
Ref: E-185-2013-0 | Updated: May 15, 2014
Role of Novel Hepatitis Delta Virus Variant in Sjogren’s Syndrome
Ref: E-736-2013-0 | Updated: Apr 14, 2014
Compositions for Modification of Genomic DNA and Exogenous Gene Expression
Ref: E-763-2013-0 | Updated: May 14, 2018
Engineering Neural Stem Cells Using Homologous Recombination
Ref: E-762-2013-0 | Updated: May 14, 2018
Human iPSC-Derived Mesodermal Precursor Cells and Differentiated Cells
Ref: E-342-2013-0 | Updated: May 14, 2018
Dengue Vaccines: Tools for Redirecting the Immune Response for Safe, Efficacious Dengue Vaccination
Ref: E-289-2013-0 | Updated: Mar 18, 2014
Rabies Vaccine for the Oral Immunization of Domesticated Animals, Wildlife and Feral Animals
Ref: E-470-2013-0 | Updated: May 24, 2016
Methods for Amelioration and Treatment of Pathogen-associated Inflammatory Response
Ref: E-236-2013-0 | Updated: Feb 19, 2014
Recombinant Sulfated HIV Envelope Protein and Methods for Making Protein
Ref: E-067-2012-0 | Updated: Apr 15, 2014
Peptide Sequences for Chlamydophila pneumoniae Vaccine and Serological Diagnosis
Ref: E-235-2013-0 | Updated: Feb 7, 2014
Recombinant Polypeptides for Clinical Detection of Taenia solium and Diagnosis of Cysticercosis
Ref: E-230-2013-0 | Updated: Feb 6, 2014
CD40 Ligand: Adjuvant for Enhanced Immune Response to Respiratory Syncytial Virus
Ref: E-233-2013-0 | Updated: Feb 6, 2014
Virus Replicon Particles as Rift Valley Fever Vaccines
Ref: E-272-2013-0 | Updated: Aug 8, 2016
Vaccine Attenuation via Deoptimization of Synonymous Codons
Ref: E-328-2013-0 | Updated: Jan 28, 2014
Therapeutic, Bifunctional Janus Microparticles with Spatially Segregated Surface Proteins and Methods of Production
Ref: E-457-2013-1 | Updated: Jan 28, 2014
Select M. tuberculosis Peptides as Mucosal Vaccines Against Pulmonary Tuberculosis
Ref: E-192-2013-0 | Updated: Jan 27, 2014
Exposure and Activity Detection Assays for Anthrax Lethal Factor and Lethal Toxin
Ref: E-196-2013-0 | Updated: Mar 3, 2017
Virus Microneutralization Assay Data Analysis for Vaccine Development, Enhancement and Efficacy Improvement
Ref: E-262-2013-0 | Updated: Jan 27, 2014
Multi-Antigenic Peptide(s) Vaccine and Immunogen for Conferring Streptococcus pneumoniae Immunity
Ref: E-248-2013-1 | Updated: Jan 27, 2014
Immunogenic Hepatitis E Virus Polypeptides for Vaccine and Diagnostics Development
Ref: E-152-2013-0 | Updated: Jan 20, 2014
Methods of Treating or Preventing Pruritis (Itch)
Ref: E-485-2013-0 | Updated: Jun 7, 2018
Respiratory Syncytial Virus Immunogens for Vaccine and Therapeutics Development
Ref: E-197-2013-0 | Updated: Jan 16, 2014
Novel Primate T-cell Lymphotropic Viruses (HTLV, STLV) for Development of Diagnostics, Therapeutics, Research Tools, and Vaccines
Ref: E-281-2013-0 | Updated: May 24, 2016
Diisocyanate Specific Monoclonal Antibodies for Occupational and Environmental Monitoring of Polyurethane Production Exposure-related Asthma and Allergy and Clinical Diagnosis
Ref: E-189-2013-0 | Updated: Jan 23, 2014
Novel Epitopes of Bacillus anthracis Lethal Factor for Development of Diagnostics and Therapeutics
Ref: E-210-2013-0 | Updated: Mar 3, 2017
Human Rotavirus Strains and Vaccines for Neonatal Childhood Protection
Ref: E-150-2013-0 | Updated: Dec 26, 2019
Intranasal Nebulizer with Disposable Drug Cartridge for Improved Delivery of Vaccines and Therapeutics
Ref: E-308-2013-0 | Updated: Jun 14, 2018
Diagnostics, Vaccines, and Delivery-Vehicles Related to Novel Phlebovirus
Ref: E-269-2013-0 | Updated: Dec 4, 2013
Broadly Neutralizing Human Anti-HIV Monoclonal Antibody 10E8 and Related Antibodies Capable of Neutralizing Most HIV-1 Strains
Ref: E-253-2011-0 | Updated: Jun 18, 2014
Therapeutic Peptide Treatment for Dyslipidemic and Vascular Disorders
Ref: E-138-2008-0 | Updated: Aug 8, 2016
Oral Treatment of Hemophilia
Ref: E-281-2001-0 | Updated: Dec 4, 2013
Subscribe to Technologies related to Therapeutic (biologic)